Evaxion A (EVAX) Cash & Current Investments (2019 - 2026)
Evaxion A (EVAX) reported Cash & Current Investments of $18.4 million for Q1 2026, up 3.35% on a YoY basis from $17.8 million in Q1 2025, and down 20.63% quarter-over-quarter from $23.2 million in Q4 2025.
Evaxion A (EVAX) Cash & Current Investments (2019 - 2026) Analysis & Trends
Evaxion A has reported Cash & Current Investments for 8 years, with the latest figure at $18.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 3.35% year-over-year to $18.4 million; the trailing twelve-month figure through Mar 2026 stood at $18.4 million (up 3.35% YoY), and the FY2025 full-year result was $23.2 million, up 290.36% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $18.4 million, down from $23.2 million in the prior quarter.
- The five-year high for Cash & Current Investments was $31.4 million in Q1 2022, with the low at $11731.0 in Q1 2024.
- Historically, Cash & Current Investments has averaged $13.3 million across 5 years, with a median of $11.9 million in 2022.
- Annual changes were most pronounced in 2024 — Cash & Current Investments slumped 99.89% — and 2025, when it soared 152001.27%.
- Evaxion A's Cash & Current Investments stood at $13.2 million in 2022, then sank by 57.65% to $5.6 million in 2023, then increased by 6.61% to $6.0 million in 2024, then jumped by 290.36% to $23.2 million in 2025, then retreated by 20.63% to $18.4 million in 2026.
- The last three Cash & Current Investments figures came in at $18.4 million (Q1 2026), $23.2 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 8.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.44 Mn |
| Dec 31, 2025 | 23.23 Mn |
| Sep 30, 2025 | 10.57 Mn |
| Jun 30, 2025 | 14.75 Mn |
| Mar 31, 2025 | 17.84 Mn |
| Dec 31, 2024 | 5.95 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 11,731.00 |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 7.12 Mn |
| Mar 31, 2023 | 10.24 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 17.85 Mn |
| Jun 30, 2022 | 25.25 Mn |
| Mar 31, 2022 | 31.41 Mn |
| Dec 31, 2021 | 32.17 Mn |
| Sep 30, 2021 | 11.94 Mn |
| Jun 30, 2021 | 18.80 Mn |
| Mar 31, 2021 | 26.96 Mn |